Daxor corporation awarded $1.1 million contract from the united states defense health agency for added capabilities to its point-of-care blood volume analyzer

Oak ridge, tn, july 05, 2023 (globe newswire) -- daxor corporation (nasdaq: dxr), the global leader in blood volume measurement technology, today announced that the united states defense health agency (dha) has awarded the company a $1.1 million sequential phase ii small business innovative research (sbir) contract to add the capability of electronic medical record (emr) integration to its small, portable, highly accurate, battery-powered blood volume analyzer.
DXR Ratings Summary
DXR Quant Ranking